Illumina, Inc. Launches GenomeStudio(TM) Data Analysis Software

SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today introduced GenomeStudio Software, a primary analysis software program designed to analyze both microarray and sequencing data. For researchers, GenomeStudio Software enables the correlation of biological variation across multiple applications and graphical display of the results. The flexibility of GenomeStudio Software also allows researchers to integrate with third-party software providers for advanced downstream analysis. GenomeStudio Software will be broadly available to researchers in November 2008.